Skip to main content
. Author manuscript; available in PMC: 2021 Jul 2.
Published in final edited form as: Eur Urol Oncol. 2018 Jun 13;1(5):364–377. doi: 10.1016/j.euo.2018.04.015

Fig. 2 –

Fig. 2 –

Selected glycosaminoglycan properties in plasma samples in the discovery set, comprising 38% of the current cohort (RCC 67, healthy 19) and two historical cohorts from Sweden (RCC 26, healthy 20) and Italy (RCC 23, healthy 5) [14]; see also Table 3. RCC = renal cell carcinoma; CS = chondroitin sulfate; HS = heparan sulfate; tot = total.